ALC.AX

Alcidion Group Limited
ASXAUDEQUITY Healthcare DELAYED
Last price
0.09
▼ 0.00 (4.21%)
MARKET ·

Price

Open
0.09
Prev close
0.10
Day high
0.10
Day low
0.09
Volume
779.63K
Market cap
$122.26M
P/E (TTM)
52W range
0.08 – 0.15

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
327.37M
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Jun 30, 25
Gepp (Matthew)
Chief Financial Officer
115.42K Direct
Apr 15, 25
Way (Andrew)
Director (Non-Executive)
126.58K Direct
Mar 4, 25
Doyle (Katrina Elizabeth)
Chief Executive Officer
SELL 5.00M $266.50K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

3 reporting
NameRelationShares heldLatest
Doyle (Katrina Elizabeth)
Chief Executive Officer 43.56M Sale
Gepp (Matthew)
Chief Financial Officer 115.42K Other
Way (Andrew)
Director (Non-Executive) 126.58K Other

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Options chain

Account required
ExpirySpot 0.09
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+1.11% +2.5%
1M
-1.09% -4.8%
3M
-17.27% -20.4%
6M
-17.27% -28.3%
YTD
-13.33% -25.6%
1Y
-9.00% -29.0%
3Y
-20.87% -95.0%
5Y
-74.23%

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported
Market cap$122.26M
Enterprise value$102.59M
Revenue (TTM)$51.64M
Gross profit$41.46M
EBITDA$7.32M
Net income$2.29M
EPS (TTM)$0.00
Free cash flow$6.85M
Total cash$20.64M
Total debt$814.00K
Book value / share$0.07
Shares outstanding1.34B
Float994.93M
Short % of float
Dividend yield
Beta (5Y)

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E26.53
PEG ratio
Price / sales
Price / book1.34
EV / revenue1.99
EV / EBITDA14.02
Gross margin80.28%
Operating margin1.28%
Profit margin4.42%
Return on equity2.56%
Return on assets1.22%
Debt / equity0.90
Current ratio1.22
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 5 years
Blank means not reported, not zero
Line item20262025202420232022YoY
Total revenue $41.81M$37.06M$40.40M$34.35M
Operating revenue $41.81M$37.06M$40.40M$34.35M
Cost of revenue $10.18M$5.14M$5.63M$4.86M
Gross profit $31.62M$31.92M$34.77M$29.49M
Selling, general & admin $28.52M$29.20M$29.14M$22.96M
Total operating expense $39.14M$40.60M$39.50M$31.22M
Operating income -$7.52M-$8.68M-$4.73M-$1.73M
Net interest income $103.00K-$20.00K-$14.00K-$44.00K
Pre-tax income $1.32M-$8.70M-$4.74M-$3.91M
Tax provision -$968.00K-$282.00K-$1.12M$504.00K
Net income $2.29M-$8.42M-$3.62M-$4.41M
Net income to common $2.29M-$8.42M-$3.62M-$4.41M
Basic EPS 0.00-0.01-0.00-0.00
Diluted EPS 0.00-0.00-0.00
EBIT $1.37M-$8.60M-$4.62M-$3.84M
EBITDA $6.38M-$4.50M-$1.43M-$1.58M
Basic shares 1.34B1.27B1.16B
Diluted shares 1.34B1.32B1.27B1.16B

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $0
Next quarter $0
Current year 0.00 3 $54.73M +6.0%
Next year 0.00 3 $59.63M +8.9%

Analyst targets & ownership

Account required
Mean target$0.15
High target$0.17
Low target$0.13
Implied upside62.09%
Analyst count4
ConsensusSTRONG BUY
Strong buy / Buy0 / 3
Hold1
Sell / Strong sell0 / 0
Held by insiders24.33%
Held by institutions10.97%
Institutions holding7
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
0.09
+0.44% from price
SMA 20
0.09
+1.17% from price
SMA 50
0.09
-3.74% from price
SMA 100
0.10
-8.13% from price
SMA 200
0.10
-11.21% from price
EMA 12
0.09
+0.08% from price
EMA 26
0.09
-0.92% from price
EMA 50
0.09
-3.44% from price
RSI (14)
48.2
Neutral
MACD (12,26,9)
-0.00
Hist 0.00
ATR (14)
0.00
4.24% of price
Realised vol 30D
38.8%
Annualised
Bollinger upper
0.09
20, 2σ
Bollinger lower
0.09
20, 2σ
50 / 200 cross
Death
0.09 vs 0.10
Trend bias
Below 200
-11.21%

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.75
Less volatile than market
Correlation to SPY
0.16
Largely independent
Realised vol 30D
38.8%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-38.6%
Peak to trough
Max drawdown 5Y
-88.6%
Peak to trough
ATR 14
0.00
4.24% of price
Beta (reported)
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.